# Treatment of Latent Tuberculosis in Socially Marginalised Citizens

> **NCT03266991** · PHASE4 · TERMINATED · sponsor: **Aarhus University Hospital** · enrollment: 22 (actual)

## Conditions studied

- Compliance, Patient

## Interventions

- **DRUG:** Rifapentine
- **DRUG:** Isoniazid

## Key facts

- **NCT ID:** NCT03266991
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-27
- **Primary completion:** 2023-02-09
- **Final completion:** 2023-02-09
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Recruitment issues
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03266991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03266991, "Treatment of Latent Tuberculosis in Socially Marginalised Citizens". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03266991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*